Journal
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
Volume 36, Issue 1, Pages 117-120Publisher
BIOLIFE SAS
Keywords
Infection; biomarkers; children; sepsis; pediatric; novel biomarkers
Ask authors/readers for more resources
Sepsis is a common and serious condition in pediatric patients, and early recognition is essential to prevent fatal outcomes. However, most research on novel serum biomarkers of infection has been conducted in adults. This article provides an overview of the current knowledge on the diagnostic efficacy of novel biomarkers of infection in pediatric patients.
Sepsis is one of the most frequent causes of morbidity and mortality in the paediatric age, and its early recognition is important to prevent its lethal outcomes. A great variety of novel serum biomarkers of infection have been investigated in the last decades, although most of the research has been performed in adult patients. We report current knowledge on this topic to assess the diagnostic efficacy of novel biomarkers of infection in paediatric patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available